Jyoti G. Yellol-rekin lankidetzan egindako argitalpenak (6)

2018

  1. A new C,N-cyclometalated osmium(ii) arene anticancer scaffold with a handle for functionalization and antioxidative properties

    Chemical Communications, Vol. 54, Núm. 79, pp. 11120-11123

2017

  1. Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action

    Chemistry - A European Journal, Vol. 23, Núm. 61, pp. 15294-15299

2016

  1. Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization

    Chemical Communications, Vol. 52, Núm. 98, pp. 14165-14168

2015

  1. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study

    Journal of Medicinal Chemistry, Vol. 58, Núm. 18, pp. 7310-7327

  2. Synthesis of 2-pyridyl-benzimidazole iridium(III), ruthenium(II), and platinum(II) complexes. study of the activity as inhibitors of amyloid-β aggregation and neurotoxicity evaluation

    Inorganic Chemistry, Vol. 54, Núm. 2, pp. 470-475

2013

  1. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes

    Chemical Communications, Vol. 49, Núm. 98, pp. 11533-11535